Marseille Immunopole ©2019 Legal notice & Privacy statement
To date, The Pioneer Project benefits from the commitment of 13 partner centers.
Update of The Pioneer Project : 173 patients in the biomarker program, 7 patients in the umbrella clinical trial
When PIONeeR meets QUANTIC
Meet our experts involved in the Pioneer Project
Highlights of the event: “MI Day Lung Cancer”
As COVID19 pandemic continues, all partners remain at work and committed to The Pioneer Project
An update of The Pioneer Project RHU: 104 patients in the biomarker component, 2 patients in the umbrella clinical trial.
MI Day: “MI Day Lung Cancer” on 6 February 2020
Immuno-oncology and lung cancer highlights: episode 2 (Q4 2019)
Update of the Pioneer Project RHU: while 91 patients have already been included in the biomarker component of the project, a first patient is entered in the Pioneer’s clinical trial
Overcome resistance to anti-PD1(L1) immunotherapy: first lung cancer patient enrolled in the Pioneer Project’s clinical trial